TheCable

The National Primary Health Care Agency (NPHCDA) says 513,626 persons have received the first dose of the AstraZeneca COVID-19 vaccine across the country.

Nigeria received 3.94 million doses of the AstraZeneca COVID-19 vaccine from the COVAX facility on March 2 and commenced vaccination on March 5 with healthcare workers.

The first shot of the vaccine was given to Cyprian Nyong, a medical doctor at the National Hospital, Abuja.

The NPHCDA had said the vaccine roll-out would be in four phases, starting with health workers, frontline workers, COVID-19 rapid response team, laboratory network, policemen, petrol station workers, and strategic leaders.

“Phase 2 – Older adults aged 50 years and above, those with co-morbidities, aged between 18 years and 49 years; Phase 3 – Those in states/LGAs with high disease burden and who missed phases 1 and 2 and Phase 4 – Other eligible population as vaccines become available,” it had said.

According to its situation update on Sunday, the agency said over 513,626 eligible people have been vaccinated in 35 states and the federal capital territory (FCT).

It said the country has vaccinated 25.5 percent of the target population against COVID-19.

The agency said Kogi state is yet to commence vaccination because the state had not been supplied with the vaccine.

“Kogi State was not supplied with the vaccines because their cold store is still under repairs following vandalisation during the EndSARS protest,” NAN quoted NPHCDA to have said.

According to NPHCDA, Lagos leads with the highest number of doses administered with 110,042 people.

Ogun state follows with 47,507 vaccination; Kaduna, 8,063, Bauchi, 32,482, Katsina, 28,918 and Kwara-26,473.

States with the lowest number of those vaccinated are Abia, 22; Taraba, 111 and Kebbi, 532

COVID-19 Vaccination Update for March 28th 2021, in 36 States + the FCT.

How’s your State doing?#YesToCOVID19Vaccine pic.twitter.com/H4Wub1gaWX

— NPHCDA (@NphcdaNG) March 28, 2021

Advertisement

The country hopes to vaccinate 70 percent of the population against the infection to achieve herd immunity.